Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

185.49 +0.01 (+0.01%)
Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,573,156
Open 185.25
Bid (Size) 184.00 (1)
Ask (Size) 186.50 (10)
Prev. Close 185.48
Today's Range 183.70 - 187.12
52wk Range 163.52 - 218.66
Shares Outstanding N/A
Dividend Yield 3.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbbVie's Migraine Drug Outperforms Generic Treatment In Head-To-Head Trial
AbbVie's atogepant showed fewer side effects and greater efficacy than topiramate in a Phase 3 migraine prevention trial. 
Via Benzinga
AbbVie’s Migraine Drug Yields Positive Outcome In Late-Stage Study Versus Topiramate, But Fails To Draw Retail Cheer
Atogepant had fewer discontinuations in the study involving 545 participants due to adverse events than Topiramate. 
Via Stocktwits
Topics Economy
Exposures Interest Rates

Performance

YTD
+3.4%
+3.4%
1 Month
-0.1%
-0.1%
3 Month
-12.6%
-12.6%
6 Month
+7.2%
+7.2%
1 Year
+8.2%
+8.2%

More News

Read More
AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Exposures Artificial Intelligence Securities Market
Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills
Via Stocktwits
Topics Government
Exposures Political
How Is The Market Feeling About AbbVie?
Via Benzinga
AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes
Via Benzinga
Roche Stock Slides After Failed Blood Cancer Trial With AbbVie, But Parkinson’s Therapy Progress Boosts Retail Mood
Via Stocktwits
AbbVie Says Cancer Drug Failed To Prolong Survival In Late-Stage Study: Retail’s On The Fence
Via Stocktwits
1 Cash-Producing Stock for Long-Term Investors and 2 to Steer Clear Of
Via StockStory
AbbVie Stock Rises After FDA Approves Expanded Treatment Scope For Mavyret, But Retail Needs More To Cheer
Via Stocktwits
Exposures Product Safety
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
Via Benzinga
Exposures Product Safety
Recent Filing Shows That Rep. Robert Bresnahan Bought Over $28K Worth of AbbVie Stock
Via Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
Via StockStory
Topics Economy Stocks
Exposures Supply Chain US Equities
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Via The Motley Fool
Topics Economy World Trade
Exposures Economy Tariff
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
Via Benzinga
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Cheap Dividend Growth Stocks to Buy Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates
4 Forever Dividend Stocks to Buy
Via The Motley Fool
Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'
Via Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AbbVie To Present Cancer Trial Data At Upcoming ASCO Event
Via Benzinga
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
Via The Motley Fool
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 185.49
When was AbbVie last traded?
The last trade of AbbVie was at 06/18/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.